Ascendis Pharma A/S (FRA:A71)
Germany · Delayed Price · Currency is EUR 206.00
+2.00 (0.98%)
Inactive · Last trade price on Apr 17, 2026
Ascendis Pharma Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 865.78 | 720.13 | 363.64 | 266.72 | 51.17 | 7.78 | |
Revenue Growth (YoY) | 134.82% | 98.03% | 36.34% | 421.20% | 557.93% | 11.87% |
Cost of Revenue | 32.02 | -94.92 | -44.26 | 44.4 | -12.14 | -3.52 |
Gross Profit | 770.87 | 625.22 | 319.38 | 222.32 | 39.04 | 4.26 |
Selling, General & Admin | -286.93 | 457.87 | 291.14 | -264.41 | 221.23 | 160.18 |
Research & Development | 132.09 | -303.62 | -307 | 413.45 | -379.62 | -295.87 |
Operating Income | -7.25 | -136.27 | -278.76 | -455.54 | -561.81 | -451.79 |
Interest Income | 69.15 | 130.31 | 5.55 | 25.46 | 34.48 | 71.76 |
Interest Expense | -163.13 | 206.69 | 100.03 | -44.07 | 50.49 | 3.91 |
Total Non-Operating Income (Expense) | -93.98 | 336.99 | 105.58 | -18.6 | 84.97 | 75.67 |
Pretax Income | -167.26 | -212.65 | -373.24 | -474.14 | -577.82 | -383.94 |
Provision for Income Taxes | -663.19 | 15.38 | 4.84 | 7.3 | 5.38 | -0.37 |
Net Income | 495.93 | -228.03 | -378.08 | -481.45 | -583.19 | -383.58 |
Net Income to Common | 495.93 | -228.03 | -378.08 | -481.45 | -583.19 | -383.58 |
Shares Outstanding (Basic) | 61 | 61 | 58 | 56 | 56 | 55 |
Shares Outstanding (Diluted) | 63 | 61 | 58 | 56 | 56 | 55 |
Shares Change (YoY) | 5.14% | 4.69% | 2.85% | 0.38% | 2.37% | 8.21% |
EPS (Basic) | 8.01 | -3.76 | -6.53 | -8.55 | -10.40 | -7.00 |
EPS (Diluted) | 7.38 | -3.76 | -6.53 | -8.55 | -10.40 | -7.00 |
Shares Outstanding | 62.11 | 61.98 | 59.84 | 56.56 | 55.94 | 54.77 |
Free Cash Flow | 60.49 | 53.9 | -306.2 | -467.36 | -495.7 | -441.35 |
Free Cash Flow Growth | 12.23% | - | - | - | - | - |
Free Cash Flow Per Share | 0.97 | 0.89 | -5.29 | -8.30 | -8.84 | -8.06 |
Gross Margin | 89.04% | 86.82% | 87.83% | 83.36% | 76.28% | 54.71% |
Operating Margin | -0.84% | -18.92% | -76.66% | -170.80% | -1097.85% | -5808.59% |
Profit Margin | 57.28% | -31.67% | -103.97% | -180.51% | -1139.63% | -4931.56% |
FCF Margin | 6.99% | 7.48% | -84.20% | -175.23% | -968.65% | -5674.38% |
EBITDA | 10.24 | -118.58 | -261.05 | -436.63 | -543.86 | -436.4 |
EBITDA Margin | 1.18% | -16.47% | -71.79% | -163.70% | -1062.76% | -5610.71% |
EBIT | -7.25 | -136.27 | -278.76 | -455.54 | -561.81 | -451.79 |
EBIT Margin | -0.84% | -18.92% | -76.66% | -170.80% | -1097.85% | -5808.59% |
Effective Tax Rate | 396.50% | -7.23% | -1.30% | -1.54% | -0.93% | 0.10% |